<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100
Image Overlay - NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100

NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100

NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100

NeuroRx and Relief Therapeutics were given the go-ahead from the independent Data Monitoring Committee (DMC) to continue their Phase IIb/III trial of RLF-100 (aviptadil) to treat respiratory failure in critically ill patients with Covid-19. No safety concerns were identified, allowing the trial will continue as planned to meet the full enrolment of 165 patients. When it comes to shipments, Yourway works at all hours to ensure that our couriers are available whenever needed – that includes picking up shipments 24/7, including weekends and holidays, with no cut-off times and no hidden fees.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?